Serna Bio is an AI-enabled drug discovery company developing small molecules targeting RNA to treat diseases with high unmet medical needs.
Employees
9
Founded
2021
Company Stage
Seed
YC Batch
W21
Product Features & Capabilities
small molecules that modulate translation and splicing, validated drug targets, RNA architecture mapping, functional RNA motifs, unique chemical libraries, internal programs, external collaborations